Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1994-11-10
|
pubmed:abstractText |
Mice hemizygous for the X-linked mutation, scurfy (sf), exhibit a fatal lymphoreticular disease that is mediated by T lymphocytes. To evaluate the respective roles of CD4 or CD8 single positive T cells in scurfy disease, neonates were treated with mAbs directed against the CD4 or CD8 molecules. Whereas mice treated with an anti-CD8 Ab developed lesions and succumbed to disease at the same time (17 days) as their untreated scurfy littermates, mice treated with an anti-CD4 Ab lived up to 11 wk before developing scurfy disease. To insure a more complete elimination of the T cell subsets, the scurfy mutation was bred onto beta 2-microglobulin (beta 2m)-deficient (CD8-less) and CD4-deficient transgenic mouse lines. Whereas there was little moderation of disease in beta 2m-deficient scurfy mice, CD4-deficient scurfy mice had markedly decreased scurfy lesions and a prolonged life span, similar to that of anti-CD4-treated sf/Y mice. Additionally, scurfy disease was transplanted into H-2-compatible nude mice through the adoptive transfer of CD4+CD8- T cells, but not CD4-CD8+ T cells. Flow-cytometric analysis revealed that sf/Y mice have an increased percentage of activated CD4+ T cells in their lymph nodes. In addition, there is an increase in the in vitro production of cytokines in the cultured splenocytes of CD8-less, but not CD4-less, scurfy mice. These data suggest that CD4+ T cells are critical mediators of disease in the scurfy mouse.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3764-74
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7930593-Animals,
pubmed-meshheading:7930593-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7930593-CD8-Positive T-Lymphocytes,
pubmed-meshheading:7930593-Cytokines,
pubmed-meshheading:7930593-Immunity, Cellular,
pubmed-meshheading:7930593-Immunologic Deficiency Syndromes,
pubmed-meshheading:7930593-Immunophenotyping,
pubmed-meshheading:7930593-Lymphocyte Depletion,
pubmed-meshheading:7930593-Lymphoproliferative Disorders,
pubmed-meshheading:7930593-Mice,
pubmed-meshheading:7930593-Mice, Mutant Strains,
pubmed-meshheading:7930593-Mice, Nude,
pubmed-meshheading:7930593-T-Lymphocyte Subsets,
pubmed-meshheading:7930593-beta 2-Microglobulin
|
pubmed:year |
1994
|
pubmed:articleTitle |
CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse.
|
pubmed:affiliation |
Biology Division, Oak Ridge National Laboratory, TN 37831-8077.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|